Analysis of Prognostic Factors in Seventy Patients Having a Complete Cytoreduction plus Perioperative Intraperitoneal Chemotherapy for Carcinomatosis from Colorectal Cancer

Journal of the American College of Surgeons

Volumn 203, Issue 6, 2006, Pages 878-886

  da Silva, Rodrigo Gomes ^a   Sugarbaker, Paul H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOSIS; COLORECTAL CANCER; CONTROLLED STUDY; DATA BASE; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PERITONEUM CANCER; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; HYPERTHERMIA, INDUCED; IRRIGATION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MITOMYCIN; PERIOPERATIVE CARE; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; PERITONEUM; PROGNOSIS; SURVIVAL RATE;

EID: 33751000229     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2006.08.024     Document Type: Article

References (39)

1. Jayne D.G., Fook S., and Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89 (2002) 1545-1550
2. Glehen O., Osinsky D., Beaujard A.C., and Gilly F.N. Natural history of peritoneal carcinomatosis from nongynecologic malignancies. Surg Oncol Clin North Am 12 (2003) 729-739
3. Katz M.H., and Barone R.M. The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancy. Surg Oncol Clin North Am 12 (2003) 673-688
4. Beaujard A.C., Glehen O., Caillot J.L., et al. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 88 (2000) 2512-2519
5. Cavaliere F., Ferri P., Rossi C., et al. Indications for integrated surgical treatment of peritoneal carcinomatosis of colorectal origin: experience of Italian Society of Locoregional Integrated Therapy in Oncology. Tumori 89 (2003) 21-23
6. Elias D., Blot F., El Otmany A., et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92 (2001) 71-76
7. Elias D., Delperro J.R., Sideris L., et al. Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreduction surgery and difficulties in conducting randomized trials. Ann Surg Oncol 11 (2004) 518-521
8. Jacquet P., and Sugarbaker P.H. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res 15 (1996) 49-58
9. Glehen O., Cotte E., Schreiber V., et al. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg 91 (2004) 747-754
10. Glehen O., Kwiatkowski F., Sugarbaker P.H., et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22 (2004) 3284-3292
11. Mahteme H., Hansson J., Berglund A., et al. Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study. Br J Cancer 26 (2004) 403-407
12. Pestieau S.R., and Sugarbaker P.H. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant versus delayed management. Dis Colon Rectum 43 (2000) 1341-1346
13. Pilati P., Mocellin S., Rossi C.R., et al. Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy of peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol 10 (2003) 508-513
14. Shen P., Hawksworth J., Lovato J., et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal cancer. Ann Surg Oncol 11 (2004) 178-186
15. Verwaal V.J., van Ruth S., de Bree E., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21 (2003) 737-743
16. Verwaal V.J., van Ruth S., Witkamp A., et al. Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 12 (2005) 65-71
17. Sugarbaker P.H. Colorectal carcinomatosis: a new oncologic frontier. Curr Opin Oncol 17 (2005) 397-399
18. Glehen O., Mohamed F., and Gilly F.N. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 5 (2004) 219-228
19. Verwaal V.J., van Tinteren H., van Ruth S., and Zoetmulder F.A. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg 91 (2004) 739-746
20. Jacquet P., Averbach A., Stephens A.D., et al. Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies. Oncology 55 (1998) 130-138
21. Recio P., and Bussey H.J.R. The pathology and prognosis of carcinoma of the rectum in the young. Proc R Soc Lond 58 (1965) 789-790
22. Chu D.Z., Lang N.P., Thompson C., et al. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factor. Cancer 63 (1989) 364-367
23. Sadegui B., Arvieux C., Glehen O., et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88 (2000) 358-363
24. Venook A. Critical evaluation of current treatments in metastatic colorectal cancer. Oncologist 10 (2005) 250-261
25. de Gramont A., Figer A., Seymour M., et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18 (2000) 2938-2947
26. Rothenberg M.L., Oza A.M., Bigelow R.H., et al. Progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. J Clin Oncol 21 (2003) 2059-2069
27. Colucci G., Gebbin V., Paoletti G., et al. Phase III randomized trial of FOLFORI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia meridionale. J Clin Oncol 23 (2005) 4866-4875
28. Elias D., and Pocard M. Treatment and prevention of carcinomatosis from colorectal cancer. Surg Oncol Clin North Am 12 (2003) 543-559
29. Slanetz Jr. C.A. The effect of inadvertent intraoperative perforation on survival and recurrence in colorectal cancer. Dis Colon Rectum 27 (1984) 792-797
30. D'Onofrio G.M., and Tan E.G. Is colorectal carcinoma in the young a more deadly disease?. Aust N Z J Surg 55 (1985) 537-540
31. Nozoe T., Ani H., Nasu S., and Sugimachick K. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol 75 (2000) 103-107
32. Papadoulos V.N., Michalopoulos A., Netta S., et al. Prognostic significance of mucinous component in colorectal carcinoma. Tech Coloproctol 8 Suppl 1 (2004) s123-s125
33. Kanemitsu Y., Kato T., Hirai T., et al. Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum 46 (2003) 160-167
34. Kang H., O'Connell J.B., Maggard M.A., et al. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum 48 (2005) 1161-1168
35. Du W., Mah J.T., Lee J., et al. Incidence and survival of mucinous adenocarcinoma of the colorectum: a population-based study from an Asian country. Dis Colon Rectum 47 (2004) 78-85
36. Gomes da Silva R., Cabanas J., and Sugarbaker P.H. Limited survival in treatment of carcinomatosis from rectal cancer. Dis Colon Rectum 48 (2005) 2258-2263
37. Yan T., Black D., Savady R., and Sugarbaker P.H. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 24 (2006) 4011-4019
38. Sugarbaker P.H., and Jablonski K. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221 (1995) 124-132
39. McQuellon R.P., Loggie B.W., Fleming R.A., et al. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur J Surg Oncol 27 (2001) 65-73